| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | CN1531540A Heterocyclic compounds and cerebral function improvers containing same as active |
| 09/21/2004 | CA2167673C Condensed benzazepine derivative and pharmaceutical composition thereof |
| 09/16/2004 | WO2004078764A1 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 09/16/2004 | WO2004078758A1 Novel fused heterocycles and uses thereof |
| 09/16/2004 | WO2004078682A2 Cyclic compounds and compositions as protein kinase inhibitors |
| 09/16/2004 | WO2004078110A2 Fused imizadoles as transforming growth factor (tgf) inhibitors |
| 09/16/2004 | WO2004058176A3 Acyclic pyrazole compounds |
| 09/16/2004 | WO2004004646A3 O-derivatized nocathiacin derivatives |
| 09/16/2004 | US20040181061 Controlling phytopathogenic fungi by treating plants, seeds or soil with, e.g., O-Methyl (6-chloro-3-propyl-4H-1,3-benz[e]oxazin-4(3H)-one)-2-oxime; higher activity and selectivity than previous derivatives |
| 09/16/2004 | US20040180942 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders |
| 09/16/2004 | CA2517850A1 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 09/15/2004 | EP1455779A1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 09/15/2004 | EP1173440B1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 09/15/2004 | EP1054669B9 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 09/15/2004 | CN1528746A Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method |
| 09/14/2004 | US6790850 Thiazolo(4,5-d)pyrimidine compounds |
| 09/10/2004 | WO2004077367A1 Tetracyclic sulfenamide compound |
| 09/10/2004 | WO2004076461A1 Porphyrin derivatives |
| 09/10/2004 | WO2004076420A1 Heteroarylcarbamoylbenzene derivative |
| 09/10/2004 | WO2004076411A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 09/10/2004 | CA2516705A1 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 09/10/2004 | CA2516407A1 Heteroarylcarbamoylbenzene derivatives |
| 09/09/2004 | US20040176605 Compounds as antumor agents or immunosuppressants |
| 09/09/2004 | US20040176396 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 09/09/2004 | US20040176390 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors |
| 09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 09/09/2004 | US20040176377 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example |
| 09/09/2004 | US20040176362 Matrix metalloproteinase inhibitors, treatment of tumor necrosis factor mediated diseases; autoimmune and neurodegenerative disorders; anticarcinogenic and antiinflammatory agents |
| 09/09/2004 | DE10308107A1 New macrocyclic peptide derivatives useful for treating bacterial infections, especially caused by Gram-positive bacteria |
| 09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 09/02/2004 | WO2004074295A1 Thiazole cycle polymers, process for producing the same, synthesis intermediates thereof and utilization of the same |
| 09/02/2004 | WO2004074291A1 Triazole compounds useful in therapy |
| 09/02/2004 | WO2004074283A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
| 09/02/2004 | WO2004074278A1 Novel compounds |
| 09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | WO2004050036A3 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | US20040171626 having good to very good inhibitory activity against HCV polymerase; hepatitis C virus |
| 09/02/2004 | US20040171620 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
| 09/02/2004 | US20040171022 Methods for regulating transcription by targeting quadruplex DNA |
| 09/02/2004 | US20040170866 Cyclic tertiary amine compound and organic electroluminescent device containing the compound |
| 09/02/2004 | CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | CA2516234A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
| 09/01/2004 | EP1452528A1 Xanthine oxidase inhibitors |
| 09/01/2004 | EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 08/31/2004 | US6784293 Solution and solid-phase synthesis of boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/ dihydrothiouracils |
| 08/31/2004 | US6784189 Potassium channel inhibitors and method |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/26/2004 | WO2004072243A2 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | WO2004045562A3 Mixed kappa/mu opioids and uses thereof |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167123 Anti-infective agents |
| 08/26/2004 | CA2515216A1 Macrocyclic hepatitis c serine protease inhibitors |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP0883616B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/25/2004 | CN1523987A Immune response modifiers for the treatment of periodontal disease |
| 08/19/2004 | WO2004069843A1 Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same |
| 08/19/2004 | WO2004069823A1 Inhibitors of histone deacetylase |
| 08/19/2004 | WO2004069245A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents |
| 08/19/2004 | US20040162285 Anti-infective agents |
| 08/19/2004 | CA2514241A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents |
| 08/19/2004 | CA2513059A1 Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same |
| 08/18/2004 | EP1446127A1 Triazepine derivatives as neurotrophic agents |
| 08/18/2004 | EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases |
| 08/18/2004 | EP0876345B1 Heterocyclic compounds as h+-atpases |
| 08/18/2004 | CN1521169A 2,4- dichlorophenoxy acetalimide derivatives of dithiazo pyridine with herbicidal activity and method for preparation thereof |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists |
| 08/12/2004 | WO2004067537A1 Triazole derivatives and antifungal agents containing the same |
| 08/12/2004 | WO2004048368A3 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 08/12/2004 | WO2004015131A3 Hepatitis c virus assays |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157853 Thiazolopytimidines and their use as modulators of chemokine receptor activity |
| 08/12/2004 | US20040157852 cancer, diabetes, hepatic cirrhosis, atherosclerosis, angiogenesis and renal disease |
| 08/12/2004 | US20040157840 Rifalazil compositions and therapeutic regimens |
| 08/12/2004 | US20040157835 selective inhibition of cyclooxygenase-2, anti-inflammatory and analgesic properties, and no side effects of causing ulcer with the treatment dosage |
| 08/12/2004 | US20040157831 Therapeutic 5-HT ligand compounds |
| 08/11/2004 | EP1445252A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 08/11/2004 | EP1444545A2 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices |
| 08/11/2004 | EP1444229A1 Pyrazole derivatives as psychopharmaceuticals |
| 08/11/2004 | EP1443822A1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones |
| 08/11/2004 | CN1161120C Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylasis treatment of obesity |
| 08/10/2004 | US6774130 Treating chronic inflammatory disease, chronic intestinal inflammation, arthritis, psoriasis, asthma and autoimmune disorders; th1 cell-mediated disorders; for example, 1,2,3,6-tetrahydro-7h-purine-2,6-dione derivatives |
| 08/10/2004 | US6774126 Pyrrolo[1,2-b][1,2,4]oxadiazine diones useful as nitric oxide synthase inhibitors |
| 08/05/2004 | WO2004065395A1 Thienopyridazinones and their use in modulation of autoimmune disease |
| 08/05/2004 | WO2004065394A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 08/05/2004 | WO2004065367A1 Viral polymerase inhibitors |
| 08/05/2004 | WO2004065366A1 2.4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 08/05/2004 | WO2004064778A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/05/2004 | WO2004064730A2 Compounds, compositions and methods |
| 08/05/2004 | WO2004039776A3 A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives |
| 08/05/2004 | WO2003059289A3 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 08/05/2004 | US20040152889 Process for the preparation of benazepril |
| 08/05/2004 | US20040152739 Bone disorders; cardiovascular disorders; gastrointestinal disorders; angiogenesis inhibitors; metabolism disorders; central nervous system disorders; traumas; skin disorders; inflammatory bowel disorders; anticancer agents |
| 08/05/2004 | CA2513501A1 2.4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 08/05/2004 | CA2512546A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/05/2004 | CA2512136A1 Thienopyridazinones and their use in modulation of autoimmune disease |